How would a foreign startup raise funds in US?

Start with the reality: US investors fund “US-ready” companies

Yes, a foreign startup can raise money in the US. In practice, most US angels and venture capital (VC) firms prefer (or require) a structure that makes investing legally simple, tax-efficient, and enforceable. “US-ready” usually means:

• A Delaware C-Corporation (a US company incorporated in Delaware) as the parent company, or at least as the fundraising entity.
• Clean cap table (cap table = who owns what %), with clear founder equity and option pool plans.
• US-friendly investment docs like a SAFE (Simple Agreement for Future Equity) or a priced equity round.
• Banking + accounting that can handle US investors (often a US bank account and US accounting/tax support).

None of this guarantees funding, but without it you’ll lose time to “we can’t invest in this structure” objections.

Pick the right fundraising path: 4 common structures

There are multiple ways to raise US capital. The “best” option depends on your stage, where your team is located, and whether you need US hiring or US customers soon.

1) Delaware C-Corp parent (most common for VC)

This is the default for venture-backed startups. You form a Delaware C-Corp and either:

• Make your existing foreign company a subsidiary, or
• Do a “flip” (the US company becomes the parent and shareholders exchange their shares).

Why investors like it: standard governance, predictable shareholder rights, and familiar documents. Why founders like it: it unlocks most US VC and many accelerators.

2) Keep the foreign company, raise from US angels selectively

Some angels will invest directly into a foreign entity, but it’s less common and often smaller checks. Expect more friction around contracts, tax forms, and enforceability. This can work if you’re raising a small pre-seed and you have strong traction.

3) US subsidiary (less ideal for equity fundraising)

A US subsidiary can help with US customers and payroll, but many investors still want to invest at the parent level. If the value is “trapped” in a foreign parent, investors may worry about control and exit mechanics.

4) Non-dilutive + revenue first, then US equity

If you can get paying US customers (or partnerships) without raising US equity immediately, you can delay the legal complexity. Later, you raise when you have stronger metrics and negotiating leverage.

Understand the US funding menu (and what each expects)

US fundraising isn’t one thing. Different capital sources have different risk tolerance and paperwork expectations.

• Angels: individuals writing checks (often $5k–$100k, varies). They care about team credibility and early traction. They may accept more “non-standard” setups than VCs, but still prefer Delaware.
• Pre-seed/seed funds: small VC funds. They usually require Delaware C-Corp and standard docs. They’ll look for a clear wedge (why you win) and early evidence (users, pilots, LOIs, revenue).
• Top accelerators: programs that invest a small amount and provide network/mentorship. Many require a US entity by program start.
• Strategic investors: corporates investing for strategic reasons. They can be slower and more complex, but may be open to international structures if it aligns with their goals.
• Revenue-based financing / venture debt: typically requires meaningful revenue and a US entity/banking. Not a first stop for most early-stage foreign founders.

Document-wise, early US rounds often use a SAFE (a contract that converts into equity later) or a priced round (you sell shares now at a set valuation). SAFEs are common in seed, but investors will still expect basic protections and clean ownership.

Key legal, tax, and compliance issues (plain-English version)

This section is not legal advice, but it will help you ask the right questions and avoid expensive rework.

Securities compliance: you’re selling an investment contract

When you raise money, you’re offering securities (shares or rights to shares). Even if you’re not in the US, US investors are subject to US securities rules. Most startups rely on exemptions (rather than registering with regulators). Your lawyer will structure this, but you should plan for:

• Investor qualification checks (e.g., many angels are “accredited investors,” meaning they meet income/net worth thresholds).
• Signed subscription/SAFE documents and proper recordkeeping.
• Clear disclosures (what you’re building, risks, use of funds).

Tax and “effectively connected income” concerns

US investors often avoid investing directly into foreign entities because of tax complexity (for example, reporting burdens or uncertain tax treatment). A Delaware C-Corp is the standard “wrapper” that reduces investor friction. Your company still needs cross-border tax planning if you have teams or IP (intellectual property) outside the US.

IP ownership: investors want the company to own the core tech

If your R&D happened in a university lab, hospital, or foreign employer, investors will ask: “Does the company actually own the IP?” You may need assignments, licenses, or clean employment/contractor agreements. This is a common diligence (diligence = verification) blocker.

Banking and payments

Many US investors want to wire funds to a US bank account. Plan for:

• Entity formation documents
• Founder IDs and compliance checks
• Basic finance ops: bookkeeping, expense policy, and monthly reporting

Immigration/visas: fundraising ≠ work authorization

You can pitch US investors from abroad, but operating in the US (working, hiring, signing certain contracts) may require visa planning. Don’t assume “I raised US money” automatically solves immigration. Treat immigration as a parallel workstream with a specialist.

How to run a US fundraising process from abroad (a practical playbook)

Fundraising is a sales process. For STEM founders, it helps to treat it like an experiment with a funnel and measurable conversion rates.

Step 1: Build the minimum “investor-ready” package

• Pitch deck (10–15 slides): problem, solution, why now, traction, business model, go-to-market, competition, team, ask.
• One-sentence positioning: “We help X do Y by Z.”
• Traction proof: pilots, LOIs (letters of intent), revenue, usage, or credible clinical/technical validation (varies by vertical).
• Data room (a folder of diligence docs): cap table, incorporation docs, IP assignments, key contracts, financial model.

Step 2: Decide your “raise shape” before you start

Investors will ask: how much are you raising, on what instrument, and what milestones will it buy? A common early-stage pattern is raising enough for 12–18 months of runway (runway = months until you run out of cash), but it varies widely.

Be able to answer:

• Amount to raise (e.g., $500k, $1.5M, $3M—whatever matches your plan)
• Use of funds (hiring, product, regulatory, sales)
• Milestones (e.g., 10 paying customers, $50k MRR, FDA pathway clarity—varies)

Step 3: Source warm intros (cold outreach is harder cross-border)

US investors heavily weight referrals. Your best sources:

• Founders who already raised in the US
• Accelerator alumni networks
• Operators in your niche (US-based advisors)
• Angels who invest internationally

If you must do cold outreach, make it specific: 3 sentences, one metric, one clear ask for a 20-minute call.

Step 4: Run a tight timeline and create momentum

Fundraising works better when meetings cluster. Aim to schedule first meetings over 2–3 weeks, then partner meetings over the next 2–3 weeks. Momentum matters because investors use social proof (“who else is in?”) to reduce perceived risk.

Step 5: Expect diligence on cross-border risks

Be ready for questions like:

• Where is the IP created and owned?
• Where are employees/contractors located and under what agreements?
• Any export controls, data residency, or privacy constraints?
• How will money move between US entity and foreign ops?

Common mistakes foreign founders make (and how to avoid them)

• Waiting to form a Delaware C-Corp until after investor interest: you can lose the round to timing. If you’re serious about US VC, plan the structure early.
• Messy cap table: too many small advisors, unclear option promises, or undocumented equity. Keep it simple and written.
• Over-indexing on valuation: early rounds are about getting the right partners and enough runway. A slightly lower valuation with strong investors can be better than a high valuation that blocks your next round.
• No US go-to-market story: even if you’re abroad, explain how you will sell in the US (channels, pricing, sales cycle, who signs).
• Ignoring immigration until the last minute: if the plan requires you in the US, start early with professionals.

What to do next

1. Choose your target investor type (angels vs seed funds vs accelerator) and write a one-page “raise plan” with amount, instrument (SAFE vs priced), and 12–18 month milestones.
2. Make your structure investable: if US VC is the goal, explore a Delaware C-Corp parent and map how your current company/IP/employees would fit.
3. Build a diligence-ready data room (cap table, incorporation docs, IP assignments, key contracts, basic financial model). Use /finances to pressure-test your runway and milestones.
4. Get 20 warm intros from founders/operators and track outreach like a funnel (contacts → meetings → follow-ups → term sheet). If you want feedback on your positioning, use /roast.
5. Run a competitor and narrative check so your “why now/why you” is crisp. Start with /Competitor_study and refine your pitch.